Alaunos Therapeutics | ZIOP - Ativos





Ativos Alterar Data
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Baxter International USD 19.79B 55M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bioline Rx USD 38.8M 2.11M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Celltrion KRW 768.81B 9.37B 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Curis USD 29.69M 9.72M 2026-03
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 201.06B 167M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Merck USD 129.8B 1.12B 2026-06
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Novartis USD 122.03B 3.5B 2026-06
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pfizer USD 201.13B 6.49B 2026-06
Pharma Mar EUR 393.6M 8.34M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Tilray USD 2.1B 15.95M 2025-09
Verastem USD 227.81M 18.63M 2026-03
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03